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Summary
Background: Atrial ﬁbrillation is commonly associated with impaired reservoir and booster func-
tions of the left atrium (LA). Recent advances in two-dimensional speckle tracking technique
(2DST) enabled automatic analysis of the time-LA volume curve representing these functions.
Our objective was to evaluate LA function in patients with or without paroxysmal atrial ﬁbril-
lation (PAF) using 2DST.Booster function Methods: We studied 111 patients (68 men, age 62± 16 years) with (n = 53) or without (n = 58)
PAF. After constructing time-LA volume curves from the apical four and two chamber views
(iE33, Philips with QLAB 6.0, Philips Medical Systems, Bothell, WA, USA), maximal LA volume
(LAVmax), preatrial contraction LA volume (LAVpreA), and minimum LA volume (LAVmin) were
obtained. Then, LA reservoir volume (ARV = LAVmax− LAVmin) and active emptying volume
(AEV = LAVpreA− LAVmin) were calculated to determine ARV/LAVmax as reservoir function and
AEV/LAVpreA as booster pump function.
∗ Corresponding author. Tel.: +81 6 76 265 2259; fax: +81 76 234 4210.
E-mail address:myamagi@med.kanazawa-u.ac.jp (M. Yamagishi).
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Results: PAF was associated with greater LAVmax than that in controls (80± 21ml versus
65± 16ml, p < 0.001) and with reduced reservoir and booster functions (ARV/LAVmax 46± 9%
versus 52± 7%; AEV/LAVpreA 29± 10% versus 36± 6%, p < 0.001). Multivariate logistic analysis
demonstrated that ARV/LAVmax and AEV/LAVpreA were closely associated with the existence of
PAF.
Conclusion: These results demonstrate that the present 2DST enables determining LA reservoir
ing
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We analyzed echocardiographic data using commerciallyand booster functions, provid
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t is well established that cardiogenic embolism could sud-
enly occlude the cerebral artery without the development
f collateral circulation, thus resulting in large infarction
ssociated with severe paralysis and/or consciousness dis-
urbance. Actually, atrial ﬁbrillation (AF) is the independent
isk factor for cardiogenic stroke and relative risk increases
p to 5 times in comparison with cases without AF [1]. There
xists a strong correlation between left atrial (LA) volume
nd occurrence of AF [2], and an enlarged LA could be a
redictive factor for the occurrence of stroke even with-
ut the evidence of AF [3]. This suggests that the diagnosis
f possible occurrence of AF at the time of sinus rhythm
s important for the prevention of cardiogenic stroke when
onsidering that paroxysmal AF (PAF) has the same impact
n the occurrence of stroke as persistent or chronic AF [4].
LA mechanical functions consist of three components at
ifferent stages of the cardiac cycle: active and passive
A enlargement, as a reservoir, associated with pulmonary
nﬂow at the time of left ventricular systole to isovolu-
etric relaxation, conduit function during early ventricular
iastole, and active systole to transfer blood, as a booster,
uring late ventricular diastole [5]. Although AF is a situa-
ion in which LA booster pump function is lost, this booster
unction as well as reservoir function could be impaired even
n PAF [6—8].
Although three-dimensional echocardiography [9] and
coustic quantiﬁcation (AQ) [10,11] have been used for
he evaluation of these LA functions, they were somewhat
omplicated to obtain reliable results. Recent advances in
wo-dimensional speckle tracking technique (2DST) enabled
nalyzing time-LA volume curve [12]. In the present study,
sing 2DST we attempted to evaluate LA function in patients
ith or without PAF examining possible indices to diagnose
AF.
ethods
tudy subjects
e studied a total of 111 patients (68 men, age 62± 16
ears) including 53 patients with PAF which was documented
y electrocardiogram (ECG) including conventional, ambu-
atory, and remote monitoring systems, and 58 patients
ho did not exhibit any cardiac abnormalities with sinus
hythm as controls. Exclusion criteria included the presence
f signiﬁcant valvular disease, intracardiac shunting, left
entricular (LV) systolic dysfunction deﬁned as LV ejection
raction (EF) < 50%, hyperthyroidism, primary pulmonary
ypertension, and respiratory disease. We also excluded
a
B
s
b
sinsights into the diagnosis of PAF.
ology. Published by Elsevier Ltd. All rights reserved.
atients who showed inadequate echocardiographic images.
ll the research protocols were approved by ethical commit-
ee and informed consent was obtained from all patients.
Patients’ characteristics in the present study included
ge, sex, height, body weight, systolic blood pressure,
iastolic blood pressure, heart rate, absence or pres-
nce of hypertension, diabetes mellitus, and dyslipidemia.
urrent drug treatments were also recorded. Hyperten-
ion was deﬁned as systolic blood pressure ≥140mmHg
nd/or diastolic blood pressure ≥90mmHg. We also deﬁned
ypertension if patients already had anti-hypertensive
edication. Diabetes mellitus was deﬁned when diabetic
atterns such as fasting plasma glucose levels ≥126mg/dl,
-h plasma glucose levels by 75 g oral glucose tolerance test
200mg/dl, or casual plasma glucose levels ≥200mg/dl
ere observed on at least two occasions. Patients who
xhibited diabetic pattern at least once and diabetic symp-
oms or retinopathy or HbA1c ≥6.5% were also deﬁned
s having diabetes mellitus. Dyslipidemia was deﬁned as
ow-density lipoprotein cholesterol ≥140mg/dl and/or high-
ensity lipoprotein cholesterol <40mg/dl or triglyceride
150mg/dl.
chocardiography
ll echocardiographic examinations were performed using
n iE33 system and an S5-1 broadband phased array trans-
ucer (Philips Medical Systems, Bothell, WA, USA). At ﬁrst,
A dimension was determined by M-mode from the paraster-
al long-axis view. Then, thickness of interventricular
eptum and posterior wall, LV end-diastolic and end-systolic
imensions, and LVEF were determined in accordance with
he guideline of the American Society of Echocardiography
13].
Using pulsed Doppler method, transmitral ﬂow velocity
uch as E and A waves, and deceleration time of E wave
E-DcT) were measured. Finally, from the apical four cham-
er view, the average of peak early and late diastolic mitral
nnular velocity (e′ and a′) between medial and lateral sides
as determined by pulsed tissue Doppler method. E/e′ was
hen calculated as an index of LV end-diastolic pressure.
nalysis of time-left atrial volume curvevailable QLAB 6.0 software (Philips Medical Systems).
rieﬂy, when we set three points at the septal and lateral
ides of mitral annulus and roof of LA in the apical four cham-
er view at LV end-diastole deﬁned as R wave on the ECG,
oftware automatically drew a region of interest (ROI) like
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Figure 1 (A) Two-dimensional speckle tracking in the left atrial wall. Red circles represent initially set regions of interest (ROIs).
White squares represent ROIs which are automatically added. Whit
Representative left atrial volume curve during a cardiac cycle. LA, lef
(For interpretation of the references to color in this ﬁgure legend, t
a horseshoe shape at the inner side of LA wall, the septal
and lateral sides of mitral annulus, and the top of LA. In
the present study, we changed the setup of the number of
points to drag and modify the shape of ROI to three at each
wall (total 9 points). After manually adjusting the ROI, LA
volume was calculated by Simpson’s rule using spline inter-
polation frame by frame throughout the cardiac cycle to
derive a time-LA volume curve (Fig. 1). Then, a time-LA vol-
ume curve was also obtained from the apical two-chamber
view as well.
Three types of LA volume were determined: maximal
LA volume (LAVmax) at the LV end-systolic phase just
beforemitral valve opening, preatrial contraction LA volume
(LAVpreA) at the beginning of P-wave on the ECG, and min-
imal LA volume (LAVmin) at the LV end-diastolic phase just
after mitral valve closure (Fig. 2). We calculated LA reser-
Figure 2 Schematic representations of time-left atrial vol-
ume curve and measurement of left atrial volume. AVC, aortic
valve closure; AVO, aortic valve opening; ECG, electrocardio-
gram; LAVmax, maximum left atrial volume; LAVmin, minimum
left atrial volume; LAVpreA, preatrial contraction left atrial vol-
ume; MVC, mitral valve closure; MVO, mitral valve opening.
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t atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.
he reader is referred to the web version of the article.)
oir volume (ARV = LAVmax− LAVmin) and active emptying
olume (AEV = LAVpreA− LAVmin) and deﬁned ARV/LAVmax
s a reservoir index and AEV/LAVpreA as a booster pump
ndex according to the published reports [5,11].
tatistical analysis
ata are shown as mean± SD. An analysis of variance
ANOVA) was performed to test for statistically signiﬁcant
ifferences between two unpaired mean values, and cate-
orical data and percentage frequencies were analyzed by
he chi-square test. PAF-associated factors were examined
y multivariate logistic analysis. We used SPSS 16.0J for Win-
ows for analysis (SPSS Inc, Chicago, IL, USA). Statistical
igniﬁcance was considered when p < 0.05.
Twenty subjects were randomly selected and analyzed
o assess reproducibility. The inter- and intraobserver vari-
bility was 5.7± 3.2% and 6.2± 3.9% for LAVmax, 7.6± 5.0%
nd 5.8± 4.9% for LAVpreA, 7.0± 4.6% and 7.7± 3.3% for
AVmin.
esults
atients’ backgrounds
ge and systolic and diastolic blood pressures were higher
n PAF than those in controls, although heart rate was
ower in controls. There were no differences in sex and BMI
etween two groups. Also there were no differences in inci-
ence of hypertension, diabetes, and dyslipidemia. Although
he use of angiotensin-converting enzyme inhibitors and/or
ngiotensin II receptor blockers was not different in both
roups, the use of -blockers was greater in PAF than that
n non-PAF (Table 1).
In echocardiographic parameters, LA dimension and E
ave velocity were greater in PAF, although E-DcT was
horter in PAF. E/e′ was greater in PAF because of sig-
iﬁcantly decreased e′ and increased E. There were no
92 M. Mori et al.
Table 1 Patients’ background.
Parameters Control group (n = 58) PAF group (n = 53) p-value
Age, years 58± 17 66± 13 0.002
Male, % 57 66 NS
Body mass index, kg/m2 23± 2.8 23± 2.4 NS
Systolic blood pressure, mmHg 132± 18 139± 18 0.023
Diastolic blood pressure, mmHg 76± 12 80± 10 0.026
Heart rate, beats/min 65± 10 60± 8 0.013
Hypertension, % 57 58 NS
Diabetes mellitus, % 16 10 NS
Dyslipidemia, % 21 16 NS
Drug treatment
ACEI or ARB, % 11 9 NS
Beta-blocker, % 3 12 0.016
Data are mean± SD.
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; PAF, paroxysmal atrial ﬁbrillation.
signiﬁcant differences in LV dimensions, LV fractional short-
ening, LV wall thickness, Awave velocity, E/A and a′ between
the two groups (Table 2).
Left atrial volume and indices of left atrial function
All data regarding LA volume and functional indices are sum-
marized in Table 3. LAVmax, LAVpreA, and LAVmin were
greater in PAF than those in controls (p < 0.05). As for
LA functions, both ARV/LAVmax as the index for reservoir
function and AEV/LAVpreA as the index for booster pump
function were lower in PAF in comparison with those in con-
trols (p < 0.05).
Determining factors for PAF
We determined the diagnostic value of the LA volume
and function in predicting PAF using logistic analysis. After
Table 2 Echocardiographic parameters.
Parameters Control group PAF group p-value
LA dimension, mm 37 ± 5 40 ± 6 0.002
LVDd, mm 45 ± 3 47 ± 5 NS
LVDs, mm 28 ± 3 29 ± 4 NS
LVFS, % 37 ± 6 38 ± 5 NS
IVS, mm 9 ± 1 9 ± 1 NS
PW, mm 9 ± 1 9 ± 1 NS
E velocity, cm/s 63 ± 18 71 ± 16 0.017
A velocity, cm/s 67 ± 20 73 ± 20 NS
E/A 1.1 ± 0.6 1.1 ± 0.5 NS
E-DcT, ms 230 ± 60 209 ± 44 0.037
e′, cm/s 8.4 ± 3.5 7.1 ± 2.0 0.017
a′, cm/s 9.8 ± 1.6 8.9 ± 2.2 NS
E/e′ 8.3 ± 3.4 10.5 ± 3.6 0.001
Data are mean± SD. a′, peak late diastolic mitral annular veloc-
ity; e′, peak early diastolic mitral annular velocity; E-DcT, E
wave deceleration time; IVS, interventricular wall thickness;
LA, left atrium; LVDd, left ventricular end-diastolic dimension;
LVDs, left ventricular end-systolic dimension; LVFS, left ventricu-
lar fractional shortening; PAF, paroxysmal atrial ﬁbrillation; PW,
posterior wall thickness.
Table 3 Left atrial volume and functional indices by two-
dimensional speckle tracking method.
Parameters Control group PAF group p-value
LAVmax, ml 65 ± 16 80 ± 21 0.002
LAVpreA, ml 49 ± 15 61 ± 19 0.037
LAVmin, ml 31 ± 10 44 ± 16 0.004
ARV/LAVmax, % 52.2 ± 7.1 46.3 ± 9.3 0.001
AEV/LAVpreA, % 35.6 ± 5.8 28.6 ± 9.6 0.001
Data are mean± SD.
AEV, active emptying volume= LAVpreA− LAVmin; ARV, atrial
reservoir volume= LAVmax− LAVmin; LAVmax, maximum left
atrial volume; LAVpreA, preatrial contraction left atrial volume;
a
t
a
(LAVmin, minimum left atrial volume; PAF, paroxysmal atrial ﬁb-
rillation.
djusting for age, sex, and presence or absence of hyper-
ension, increases in LAVmax, and decreases in ARV/LAVmax
nd AEV/LAVpreA were associated with the existence of PAF
Table 4).
Table 4 Adjusted odds ratio for paroxysmal atrial
ﬁbrillation.
Odds ratio (95%CI) p-value
LAVmax, ml 1.534 (1.186—1.983) 0.001
(/10ml increase)
LAVmax/BSA, ml/m2 2.135 (1.335—3.414) 0.002
(10 ml/m2 increase)
ARV/LAVmax, % 1.457 (1.117—1.900) 0.005
(5% decline)
AEV/LAVpreA, % 1.835 (1.334—2.523) <0.001
(5% decline)
Data are mean± SD.
AEV, active emptying volume= LAVpreA− LAVmin; ARV, atrial
reservoir volume= LAVmax− LAVmin; BSA, body surface area;
CI, conﬁdence interval; LAVmax, maximal left atrial volume;
LAVpreA, preatrial contraction left atrial volume.
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Discussion
Occurrence of paroxysmal atrial ﬁbrillation and
left atrial function
Enlargement of LA is known to be related to aging, hyper-
tension, and LV diastolic dysfunction, and is an independent
factor for occurrence of AF [14—17]. In the present study,
LAVmax was found to be an independently associated fac-
tor for paroxysmal AF even after adjusting for other factors
such as aging, sex, and presence of hypertension. On the
other hand, enlargement of LA reﬂects the duration of AF
periods, because AF itself can enhance LA remodeling [17].
In addition to LAVmax, LAVpreA and LAVmin were found
to be greater in PAF than those in controls. Fatema et al.
[18] reported that not only LAVmax but also LAVmin were
independent predicting factors for AF, and, under these con-
ditions, LAVmin might be better than LAVmax in terms of
predicting value for AF. However, as pointed out in a previ-
ous [18] and in our study, reproducibility for measurement
of LAVmin was found not enough to use for clinical practice.
LA reservoir function is considered as a combination of
active LA dilation and passive dilation due to declining of
mitral annulus associated with LV contraction. Abhayaratna
et al. [19] demonstrated that the probability of occurrence
of AF would increase by 9 times in patients with LAV-
max/BSA ≥38ml/m2 and ARV/LAVmax ≤49% in comparison
with patients with LAVmax/BSA <38ml/m2 and ARV/LAVmax
>49%. This suggests that in addition to LA volume, evalua-
tion of LA function should be done to predict the occurrence
of AF.
LA reservoir function can represent LA diastolic function
and can be evaluated by the strain-rate imaging method.
Wang et al. [7] reported that hypertensive patients with
PAF exhibited lower LA strain rate than those without PAF,
suggesting that LA reservoir function may reﬂect the pro-
gression of atrial remodeling because the recurrence rate of
AF after catheter ablation was higher in patients with low
strain rates of left ventricle and atrium [20]. The present
ARV/LAVmax actually represented LA reservoir function and
was reduced in PAF, suggesting that this reﬂected the
impaired reservoir function. From the time-LA volume curve
obtained by 2DST, we can obtain ﬁrst derivation curve which
also represents the strain rate of the whole left atrium.
Unfortunately, it was somewhat difﬁcult to obtain reliable
data regarding peak value of this index from the present
study because of the presence of artifact due to noise. How-
ever, it will be possible to overcome these difﬁculties if
adequate frame rates and adequate noise ﬁlters are chosen.
LA booster pump function can increase in accor-
dance with increase in LA preload until disruption of
Frank—Starling law and contribute to maintaining cardiac
output [5,21]. However, this function may decrease in accor-
dance with progression of LA remodeling associated with AF
[22]. Cui et al. [8] reported that AEV/LAVpreA which was
determined by AQ method was signiﬁcantly lower in PAF
with hypertension than that without PAF. As for other indices
for assessment of LA function, A wave velocity [23] and tis-
sue Doppler-derived a′ [24] were used. In the present study,
there were signiﬁcant differences in AEV/LAVpreA despite
the absence of signiﬁcant differences in A wave and a′, sug-
A
S
S93
esting that AEV/LAVpresA determined by 2DST is more sen-
itive in the evaluation of LA remodeling in clinical settings.
wo-dimensional speckle tracking method
reviously, measurement of LA volume for time-LA vol-
me curve analysis has been performed by the AQ method
10,11]. However, it is somewhat difﬁcult to exclude the
resence of pulmonary vein and/or LA appendage, thus
esulting in inadequate quantiﬁcation of LA volume, because
utomatic determination of blood-tissue border by the AQ
ethod is performed within an oval ROI [25]. In contrast,
n the 2DST method we can set an ROI freely and adjust
t on looking at the situation of tracking. Therefore, one
ight speculate that measurement might be more accurate
n 2DST than that in AQ.
Although LA volume determined by three-dimensional
chocardiography coincided well with that determined by
agnetic resonance imaging [9], this procedure requires
ome technical experience and time. We previously reported
hat LA volume measured by 2DST coincided well with
hat by real-time three-dimensional echocardiography [26].
gawa et al. [27] demonstrated that time to create time-LA
olume curve by 2DST was much shorter than that by man-
al examination. Okamatsu et al. [12] studied 140 subjects
y 2DST on LA reservoir and booster functions and demon-
trated impaired reservoir and enhanced booster functions
ere observed in old people. This suggests the higher sen-
itivity of the present study to detect the LA reservoir and
ooster functions than previous methods in clinical settings,
lthough we did not compare each methodology.
tudy limitations
here remain several limitations in the present study. First,
e examined patients without evidenced PAF as controls.
owever, we could not exclude the possibility that these
ontrols might have an asymptomatic AF. Also it was difﬁ-
ult to determine the adequate cutoff value in each index
ecause of the limited number of subjects. Second, the
resent study was not longitudinal but a transverse study
nd, thus, it is difﬁcult to predict the occurrence of AF
nd/or thromboembolism. To complete this issue, additional
ollow-up study will be required to determine absolute value
f these indices for predicting the occurrence of clinical
vents.
onclusions
he present study demonstrates that using 2DST LA reser-
oir and booster functions in PAF are impaired in comparison
ith controls. We suggest that the indices obtained by the
resent method provide alternative objective ﬁndings for
redicting possible occurrence of PAF.
cknowledgmentspart of this work was presented at the 57th Annual
cientiﬁc Sessions, Japanese College of Cardiology, 2009,
apporo, Japan.
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